Pharma Journalist -

Neurim Pahrmaceuticals and BIOCODEX undertake a license agreement that enlists the fact that BIOCODEX will possess the exclusive marketing rights to market Neurim's Rx paediatric…
Read More...

MiMedx Group confirmed the enrollment of first patients in the Company's Phase 3 Investigational New Drug (IND) Clinical Trial for MiMedx's micronized amniotic tissue, AmnioFix…
Read More...

GC Pharma, a South Korean biopharmaceutical company affirmed that it will conduct Phase 2/3 clinical trial for GC1102, the company's investigational recombinant hepatitis B immune…
Read More...

APRINOIA Therapeutics into  tau, alpha-synuclein, and novel targets for neurodegenerative diseases declared the completion of its US$11.1 million Series B round to finance preclinical…
Read More...

CompleWare and YPrime  partner to offer enhanced service offerings involving Clinical Trials, electronic clinical outcome assessment (eCOA) technology and interactive response…
Read More...

In a bid to ensure transparency and clarity in their drug approval decisions,  U.S FDA Commissioner Scott Gottlieb endeavors to undertake new drug innovation and Scientific progress by…
Read More...

Ophthalmic Pharmaceutical Company, Aerie Pharmaceuticals that seeks to treat patients with open-angle glaucoma and other diseases of the eye declared the appointment of Nils Hauptmann…
Read More...

Ophthotech Corporation enrolled first patient in the Phase 2b randomized, double-masked, sham-controlled clinical trial assessing the efficacy and safety of Zimura complement C5…
Read More...

Developer of surgical implants for treating distal extremity pathology, Centric Medical asserted that the U.S FDA has granted 510 (k) clearance to the Cannulated Screw Internal Fixation…
Read More...

Genetic screening and counseling services company, Counsyl sought approval from the New York State Department of Health to provide Prelude Prenatal Screen in New York therefore…
Read More...